The prevalence of multimorbidity: discussion about the terminology, registration and its effect on patient’s health care utilization
- 作者: Chukayeva I1, Samorodskaya I2, Larina V1
-
隶属关系:
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- State Research Center for Preventive Medicine, Ministry of Health of Russia
- 期: 卷 90, 编号 8 (2018)
- 页面: 125-130
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32827
- DOI: https://doi.org/10.26442/terarkh2018908125-130
- ID: 32827
如何引用文章
全文:
详细
作者简介
I Chukayeva
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russiaд.м.н., проф., зав. каф. поликлинической терапии лечебного факультета РНИМУ им. Н.И. Пирогова; ORCID: 0000-0002-1968-1614 Moscow, Russia
I Samorodskaya
State Research Center for Preventive Medicine, Ministry of Health of Russiaд.м.н., проф., руководитель лаб. демографических аспектов здоровья населения ГНИЦ профилактической медицины; тел.: +7(985)224-60-50; ORCID: 0000-0001-9320-1503 Moscow, Russia
V Larina
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Email: larinav@mail.ru
д.м.н., проф. каф. поликлинической терапии лечебного факультета РНИМУ им. Н.И. Пирогова; ORCID: 0000-0001-7825-5597 Moscow, Russia
参考
- Glynn L.G, Valderas J.M, Healy P, Burke E, Newell J, Gillespie P, Murphy A.W. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011 Oct;28(5):516-523. doi: 10.1093/fampra/cmr013
- Valderas J.M, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009 Jul-Aug;7(4):357-363. doi: 10.1370/afm.983
- Ording A, Sorensen H. Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs. Clin Epidemiol. 2013;5:199-203. doi: 10.2147/CLEP.S45305
- Wallace E, Guthrie B, Lewi C, Fahey T, Smith S. Managing patients with multimorbidity in primary care. BMJ. 2015;350. doi: 10.1136 /bmj.h176
- Mercer S, Smith S, Wyke S. Multimorbidity in primary care: developing the research agenda. Fam Pract. 2009;26(2):79-80. doi: 10.1093/ fampra/cmp020
- Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ. 2016;354:i4843 doi: org/10.1136/bmj.i4843
- Kirchhof P, Benussi S, Dipak Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016;37:2893-2962. doi: 10.1093/eurheartj/ehw210
- Pefoyo A, Bronskill S, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, Maxwell C, Bai Y, Wodchis W. The Increasing Burden and Complexity of Multimorbidity. BMC Public Health. 2015;15(415). doi: 10.1186/ s12889-015-1733-2
- Glynn L, Valderas J, Healy P, Burke E, Newell J, Gillespie P, Murphy A. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28(5):516-523. doi: 10.1093/ fampra/cmr013
- Van Oostrom S, Picavet H, van Gelder B, Lemmens L, Hoeymans N, van Dijk C, Verheij R, Schellevis F, Baan C. Multimorbidity and comorbidity in the Dutch population - data from general practices. BMC Public Health. 2012;12:715. doi: 10.1186/1471-2458-12-715
- Fortin M, Dubois M, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes. 2007;5:52. doi: 10.1186/1477-7525-5-52
- Fortin M, Hudon C, Haggerty J, Akker M.V, Almirall J. Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Health Serv Res. 2010;10:111. doi: 10.1186/1472-6963-10-111
- O'Kelly S, Smith S, Lane S, Teljeur C, O'Dowd T. Chronic respiratory disease and multimorbidity: prevalence and impact in a general practice setting. Respir Med. 2011;105(2):236-242. doi: 10.1016/j. rmed.2010.07.019
- Uijen A, van de Lisdonk E. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract. 2008;14 Suppl 1:28-32. doi: 10.1080/13814780802436093
- Agborsangaya C, Lau D, Lahtinen M, Cooke T, Johnson J. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross - sectional survey. BMC Public Health. 2012;12:201. doi: 1471-2458-12-201
- Rocca W, Boyd C, Grossardt B, Bobo W, Rutten L, Roger V. Prevalence of multimorbidity in a geographically defined american population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc. 2014;89(10):1336-1349. doi: 10.1016/j.mayocp.2014.07.010
- Вёрткин А.Л. Коморбидность: история, современное представление, профилактика и лечение. Кардиоваскулярная терапия и профилактика. 2015;14(2):74-79. doi: 10.15829/ 1728-8800-2015-2-74-79
- Barnett K, Mercer S, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross - sectional study. Lancet. 2012;380(9836):37-43. doi: S0140-6736(12)60240-2
- Laux G, Kuehlein T, Rosemann T, Szecsenyi J. Co - and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project. BMC Health Serv Res. 2008;8:14. doi: 10.1186/1472-6963-8-14
- Mahmoudpour S, Baranova E, Souverein P, et al. on behalf of the PREDICTION-ADR consortium. Determinants of Angiotensin Converting Enzyme - inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink. Br J Clin Pharmacol. 2016;82(6): 1647-1659. doi: 10.1111/bcp.13090